Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Ariella who wrote (990)	7/14/1998 1:04:00 PM
From: Rick Strange	Read Replies (1) \| Respond to of 1491

Ariella, I liked the part that said: "we projected revenues in Q3, but will be able to post them in Q2." Nice surprise.

To: Ariella who wrote (990)	7/14/1998 3:01:00 PM
From: Tony van Werkhooven	Respond to of 1491

Ariella or Zvi -- The Globes article was good in that it put things into the proper perspective. Would it be worthwhile that whoever contacted the Post previously forward this article with the appropriate cover note. Thanks. By the way, enjoy the great commentary on this thread. Tony van Werkhooven

To: Ariella who wrote (990)	7/14/1998 3:43:00 PM
From: Don Walster	Read Replies (2) \| Respond to of 1491

Dear Ariella: The Globes article was a shot in the arm to those of us who own Pharmos. I see two problems: 1. How do we get the message out to someone beside us cheerleaders? 2. In view of the following from Globes, how long are we going to have to wait? "If everything goes as planned, Pharmos expects to submit the drug to the US Food and Drug Administration for approval in three to four years." Ariella, it seems to me that the long wait would discourage investors. Would you agree? Kindest regards, Don